Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 1, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 165,947 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on November 30, 2006, and the company was advised of it on December 1, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The transaction is noted as being in accordance with Disclosure Rule 3.1.4R(1)(b). The GSK Trust is identified as a discretionary trust where all employees or former employees are potential beneficiaries.
Key Facts for Investor Verification
- Transaction Date: November 30, 2006.
- Shares Transferred: 165,947 Ordinary Shares.
- Source: GlaxoSmithKline Employee Trust (GSK Trust).
- Beneficiaries: Participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Director Interest: Directors Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop hold interests in the GSK Trust shares in the same capacity as other employees.